Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Checkmate Pharmaceuticals Inc (CMPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2001	03-2000	03-1999	03-1998	03-1997
Cash Flows From Operating Activities
Net Income	-6,778	5,243	-10,079	0	0
Depreciation Amortization	3,823	3,429	4,459	0	0
Income taxes - deferred	-4,394	2,015	-2,437	0	0
Accounts receivable	8,043	-7,861	3,845	0	0
Accounts payable and accrued liabilities	-9,311	4,430	-1,927	0	0
Other Working Capital	7,117	-9,950	17,076	0	0
Other Operating Activity	2,680	3,306	3,296	0	0
Operating Cash Flow	$1,180	$612	$14,233	$0	$0

Cash Flows From Investing Activities
PPE Investments	-5,028	12,323	-5,290	0	0
Net Acquisitions	-137	-13,939	N/A	0	0
Investing Cash Flow	$-5,165	$-1,616	$-5,290	$0	$0

Cash Flows From Financing Activities
Debt Issued	170,792	164,753	151,430	0	0
Debt Repayment	-165,768	-161,153	-160,099	0	0
Common Stock Repurchased	N/A	-755	-962	0	0
Dividend Paid	-958	-638	N/A	0	0
Financing Cash Flow	$4,066	$2,207	$-9,631	$0	$0

Exchange Rate Effect	-93	-43	-53	0	0
Beginning Cash Position	1,559	399	1,140	0	0
End Cash Position	1,547	1,559	399	0	0
Net Cash Flow	$-12	$1,160	$-741	$0	$0

Free Cash Flow
Operating Cash Flow	1,180	612	14,233	0	0
Capital Expenditure	-5,028	-3,007	-5,290	0	0
Free Cash Flow	-3,848	-2,395	8,943	0	0